Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Screening for functional circular RNAs using the CRISPR–Cas13 system
Siqi Li, Xiang Li, Wei Xue, et al.
Nature Methods (2020) Vol. 18, Iss. 1, pp. 51-59
Open Access | Times Cited: 258

Showing 1-25 of 258 citing articles:

The emerging roles of circRNAs in cancer and oncology
Lasse S. Kristensen, Theresa Jakobsen, Henrik Hager, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 3, pp. 188-206
Closed Access | Times Cited: 805
Circular RNAs: Characterization, cellular roles, and applications
Chu‐Xiao Liu, Ling‐Ling Chen
Cell (2022) Vol. 185, Iss. 12, pp. 2016-2034
Open Access | Times Cited: 623
Targeting circular RNAs as a therapeutic approach: current strategies and challenges
Alina T. He, Jinglei Liu, Feiya Li, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 373
CRISPR in cancer biology and therapy
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 291
Specific expression and functions of circular RNAs
Sema Mısır, Nan Wu, Burton B. Yang
Cell Death and Differentiation (2022) Vol. 29, Iss. 3, pp. 481-491
Open Access | Times Cited: 245
Biogenesis and Regulatory Roles of Circular RNAs
Li Yang, Jeremy E. Wilusz, Ling‐Ling Chen
Annual Review of Cell and Developmental Biology (2022) Vol. 38, Iss. 1, pp. 263-289
Open Access | Times Cited: 177
Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
Chen Xue, Ganglei Li, Juan Lü, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 146
Comprehensive landscape and future perspectives of circular RNAs in colorectal cancer
Fei Long, Zhi Lin, Liang Li, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 140
High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects
Huawei Tong, Jia Huang, Qingquan Xiao, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 1, pp. 108-119
Open Access | Times Cited: 133
Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects
Malgorzata Ewa Rogalska, Claudia Vivori, Juan Valcárcel
Nature Reviews Genetics (2022) Vol. 24, Iss. 4, pp. 251-269
Closed Access | Times Cited: 133
Best practice standards for circular RNA research
A. Nielsen, Albrecht Bindereif, Irene Bozzoni, et al.
Nature Methods (2022) Vol. 19, Iss. 10, pp. 1208-1220
Open Access | Times Cited: 126
Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer
Hao Shen, Boqiang Liu, Junjie Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 104
CRISPR‐Cas Biochemistry and CRISPR‐Based Molecular Diagnostics
Zhengyan Weng, Zheng You, Jie Yang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 17
Open Access | Times Cited: 103
Going circular: history, present, and future of circRNAs in cancer
Giuseppina Pisignano, David C. Michael, Tanvi H. Visal, et al.
Oncogene (2023) Vol. 42, Iss. 38, pp. 2783-2800
Open Access | Times Cited: 102
CRISPR/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells
Yuxi Ai, Dongming Liang, Jeremy E. Wilusz
Nucleic Acids Research (2022) Vol. 50, Iss. 11, pp. e65-e65
Open Access | Times Cited: 98
Circular RNA translation: novel protein isoforms and clinical significance
Shuo‐Yang Wen, Javeria Qadir, Burton B. Yang
Trends in Molecular Medicine (2022) Vol. 28, Iss. 5, pp. 405-420
Closed Access | Times Cited: 91
CircOGDH Is a Penumbra Biomarker and Therapeutic Target in Acute Ischemic Stroke
Yanfang Liu, Yufeng Li, Jiankun Zang, et al.
Circulation Research (2022) Vol. 130, Iss. 6, pp. 907-924
Open Access | Times Cited: 90
A guide to naming eukaryotic circular RNAs
Ling‐Ling Chen, Albrecht Bindereif, Irene Bozzoni, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 1, pp. 1-5
Closed Access | Times Cited: 76
CRISPR technologies for genome, epigenome and transcriptome editing
Lukas Villiger, Julia Joung, Luke W. Koblan, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 464-487
Closed Access | Times Cited: 73
Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Contribution of semen to early embryo development: fertilization and beyond
Montserrat Vallet-Buisan, Rajwa Mecca, Céline Jones, et al.
Human Reproduction Update (2023) Vol. 29, Iss. 4, pp. 395-433
Open Access | Times Cited: 56
New insight into circRNAs: characterization, strategies, and biomedical applications
Xin-Yi Feng, Shun-Xin Zhu, Ke‐Jia Pu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 50
Circular RNA in cancer
Vanessa M. Conn, Arul M. Chinnaiyan, Simon J. Conn
Nature reviews. Cancer (2024) Vol. 24, Iss. 9, pp. 597-613
Closed Access | Times Cited: 40
Structures, mechanisms and applications of RNA-centric CRISPR–Cas13
Hui Yang, Dinshaw J. Patel
Nature Chemical Biology (2024) Vol. 20, Iss. 6, pp. 673-688
Closed Access | Times Cited: 26
C-to-G editing generates double-strand breaks causing deletion, transversion and translocation
Min Huang, Yining Qin, Yafang Shang, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 2, pp. 294-304
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top